Strides Arcolab has announced that it has received US Food and Drug Administration (FDA) approval for Midazolam injection multiple-dose vials.

Midazolam, a general anaesthetic, is given as a sterile, non-pyrogenic parenteral dosage form for intravenous or intramuscular injections.

The injection is expected to be launched under the partnership between Strides and Sagent.

Strides has already received FDA approval for single-dose vials.